Aims This study aimed to investigate the impact of cardiac resynchronization therapy with a
defibrillator (CRT-D) on mortality, comparing it with CRT with a pacemaker (CRT-P) …

Aims Cardiac resynchronization therapy (CRT) is an established treatment for heart failure.
There is contradictory evidence whether defibrillator capability improves prognosis in …

Background: Cardiac resynchronization therapy (CRT) represents a major medical advance
in patients with heart failure with electrical dyssynchrony to improve symptoms, reduce …

For over 100 years, metals and their alloys have played a central role in the advancement of
medical implant applications across virtually all medical specialties. Early metal implants …

Background Current guidelines did not provide recommendations on indications of an
additional implantable cardioverter‐defibrillator (ICD) to patients receiving cardiac …

Background Trends of de novo implantation of cardiac implantable electronic devices
(CIEDs) including implantable cardioverter‐defibrillator (ICD) and cardiac resynchronization …

Cardiac resynchronization therapy (CRT) is an established treatment for patients with heart
failure (HF), myocardial dysfunction and prolonged ventricular depolarization on surface …

Cardiac resynchronization therapy (CRT) is an estab-lished treatment for patients with
advanced heart failure. 1 CRT can be delivered through a pacemaker (CRT-P) or a …

Background Cardiac resynchronization therapy (CRT) is a major device therapy used to
treat patients suffering from heart failure (HF) and electrical asynchrony. It can improve HF …

Background Recent studies have questioned the role of implanted cardiac defibrillators
(ICDs) in nonischemic cardiomyopathy (NICM). Cardiac resynchronization therapy (CRT) …